What an inspiring few days at bio:cap 2026 in Berlin last week.
Bringing together investors, entrepreneurs, scientists, healthcare leaders and innovators from across Europe and beyond, the conference highlighted the tremendous momentum currently driving the life sciences sector. From AI and precision medicine to diagnostics, longevity and healthcare innovation, the discussions reinforced a shared conviction that the future of healthcare will be increasingly data-driven, personalized and interconnected.
A particular highlight for Leo International Precision Health (LIPH) was the participation of our Chairman of the Supervisory Board and Chairman of Leo International Group Leo Wang, in the panel discussion "Family Offices and the Next Wave of Life Sciences Investment." Together with fellow investors and family office leaders, the discussion explored how patient capital, long-term thinking and strategic investment approaches can help accelerate innovation and support the next generation of healthcare companies.
At LIPH, we believe that some of the most compelling opportunities in healthcare lie not only within individual companies, but in the creation of integrated ecosystems that connect AI, diagnostics, clinical care and preventive health solutions. The many conversations throughout the conference further strengthened our conviction that the industry is moving toward more intelligent, connected and scalable healthcare models.
Thank you to the organizers, speakers and everyone we had the pleasure of meeting. We look forward to continuing the dialogue and contributing to the future of precision healthcare.
